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Abstract
Background—Psychotic disorders are characterized by aberrant neural connectivity. Alterations
in gyrification, the pattern and degree of cortical folding, may be related to the early development
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of connectivity. Past gyrification studies have relatively small sample sizes, yield mixed results for
schizophrenia (SZ), and are scant for psychotic bipolar (BP) and schizoaffective (SZA) disorders
and for relatives of these conditions. Here we examine gyrification in psychotic disorder patients
and their first-degree relatives as a possible endophenotype.
Methods—Regional Local Gyrification Index (LGI) values, as measured by FreeSurfer software,
were compared between 243 controls, 388 psychotic disorder probands, and 300 of their first-
degree relatives. For patients, LGI values were examined grouped across psychotic diagnoses and
then separately for SZ, SZA, and BP. Familiality (heritability) values and correlations with clinical
measures were also calculated for regional LGI values.
Results—Probands exhibited significant hypogyria compared to controls in three brain regions
and relatives with axis II cluster A disorders showed nearly significant hypogyria in these same
regions. LGI values in these locations were significantly heritable and uncorrelated with any
clinical measure. Observations of significant
Conclusions—Psychotic disorders appear to be characterized by significant regionally localized
hypogyria, particularly in cingulate cortex. This abnormality may be a structural endophenotype
marking risk for psychotic illness and it may help elucidate etiological underpinnings of psychotic
disorders.
Keywords
Cortical folding; gyrification; psychosis; schizophrenia; bipolar; schizoaffective
Introduction
The underlying genetic architecture of psychotic disorders has proven difficult to establish,
partly because of the disorders' complex nature, clinical heterogeneity, and imprecise
diagnostic boundaries (1). Endophenotype strategies have been increasingly employed in
efforts to identify liability-conferring genes and clarify disease etiology (2).
Endophenotypes, or intermediate phenotypes, are measurable biological traits that are
“inteiflediate” between genotype and clinical syndrome. Because endophenotypes are
presumed relatively proximal to the neurobiological action of genes, they may provide
footholds in the study of the genetic underpinnings of disease (3; 4). Gottesman and Gould
(5) and others (3; 6; 7) proposed criteria for useful endophenotypes, including illness
association, heritability, state independence, and greater presentation in unaffected family
members than in the general population.
Abnormal gyrification, the degree and pattern of folding ofbrain cortex, has been proposed
as a schizophrenia endophenotype candidate (8). Schizophrenia is characterized by aberrant
connectivity (9-11) and gyrification may be related to the early development of neural
connectivity (12-15). It has been suggested that cortical connectivity development in the
second trimester generates fiber tension, which draws densely connected regions together,
forming bulging gyri, whereas more sparsely connected regions drift apart and are separated
by inward sulci (16). The case for abnormal gyrification being an endophenotype for
schizophrenia is supported by the presumed neurodevelopmental nature of the disorder,
demonstrated heritability of gyrification (17) and observations of atypical cortical folding in
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both schizophrenia probands (16; 18-28) and, to a lesser degree, unaffected relatives
(29-31).
However, gyrification findings in schizophrenia patients are notably discordant, as studies
alternately report hypogyria, hypergyria, and negative findings (Table 1). Evidence is also
inconclusive in studies of other psychotic disorders, with gyrification research on psychotic
bipolar disorder producing both positive (32-34) and negative findings (35; 36) while
research on schizoaffective disorder remains scant. These diverse findings may be due to a
variety of factors, including relatively small sample sizes and the heterogeneity of tools used
to measure gyrification. In past research, gyrification has most commonly been quantified
using the Gyrification Index (GI), a measure in two-dimensional space that may be
dependent on imaging parameters such as slice thickness and orientation (20).
It also remains unknown whether abnormal gyrification qualifies more broadly as an
endophenotype marking psychosis liability. To our knowledge, no previous study has
examined gyrification in psychotic disorders treating schizophrenia, schizoaffective
disorder, and psychotic bipolar disorder patients in the same sample. However, psychotic
disorders exhibit similar characteristics including cross-cutting symptom profiles (41),
overlapping diagnoses within family lineages (42-45), and common susceptibility genes
(46-48). This high degree of similarity underscores the importance of evaluating candidate
endophenotypes across psychotic diagnoses. It also highlights the nosological uncertainty
surrounding psychotic disorders (49) and raises questions about the relationship between
their etiologies.
The Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) is a multisite
consortium designed to characterize potential endophenotypes across the psychosis
spectrum. Here we report gyrification findings from the B-SNIP consortium calculated from
three-dimensional surface reconstructions using the Local Gyrification Index (LGI). In so
doing, we first evaluated the candidacy of gyrification as a psychotic disorder
endophenotype. To address this question, we examined familiality ofLGI measures and also
examined LGI measures in first degree relatives as an overall group, as well as relatives
defined by the presence of a psychopathology liability trait, i.e. axis II cluster A personality
disorders (50; 51).
Second, we examined whether patterns of gyrification differ between psychosis diagnoses to
evaluate specificity of this biomarker for symptom-based categories, such as schizophrenia,
bipolar, and schizoaffective disorders. Precautions were taken to avoid possible medication
confounds, as lithium and antipsychotic usage have been found to have structural effects
(52-61).
Methods and Materials
We compared MRI-derived regional local gyrification index data between healthy controls,
probands with schizophrenia (SZ), schizoaffective disorder (SZA), or psychotic bipolar
disorder (BP), and their first-degree relatives. Data were derived from B-SNIP, which
represents a 6-site (Wayne State University, Harvard University, Maryland Psychiatric
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Research Center, University of Chicago / University of Illinois at Chicago, University
ofTexas Southwestern, and the Institute ofLiving / Yale University) to uncover intermediate
phenotypes of psychotic disorders.
Study Participants
The study included 257 healthy control participants, 441 probands with a psychotic disorder
(177 SZm 106 SZA, and 158 BP) and 309 of their first-degree relatives from the B-SNIP
database on whom 3.0 Tesla MRI data, clinical measures, and demographic information
were available.
All participants met the following inclusion criteria: (1) ages 15-65; (2) sufficient
proficiency in English to understand task instructions; (3) no known history of neurologic
disorders including head injury; (4) no history of substance abuse within the last month or
substance dependence within the last 6 months; and (5) negative urine toxicology screen on
day of testing. Control subjects met the following additional criteria: (1) no personal or
family history (first degree) of psychotic or bipolar disorders; (2) no personal history of
recurrent mood disorder; (3) no lifetime history of substance dependence; (4) no history of
any significant cluster A axis II personality features defined by meeting full or within one
criteria of a Cluster A diagnosis using the Structured Interview for DSM-IV-TR Personality
(SID-P) (62). Institutional review boards at each site approved the study and all sites used
identical diagnostic, clinical, and recruitment techniques (63).
All participants underwent a diagnostic interview using the Structured Clinical Interview for
DSM-IV-TR (SCID-IV) (64) and were categorized by diagnosis. Relatives without
psychosis and controls were also administered the SID-P. Diagnoses were made at each site
by a consensus process led by a senior clinician that included reviews of results from the
clinical interviews, psychiatric and medical histories, and medical records when available.
Symptom ratings were completed with probands by a trained rater blind to MRI data using
the Positive and Negative Symptom Scale (PANSS) (65), the MontgomeryAsberg
Depression Rating Scale (MADRS) (66), and the Young Mania Rating Scale (YMRS) (67).
Clinical and structural data were available in 1014 included participants (253 controls, 179
SZ, 100 SZA, 150 BP, and 332 relatives). 83 participants (10 controls, 22 SZ, 10 SZA, 9 BP,
and 32 relatives) were excluded due to motion and scanner artifacts. A chi-squared test
showed that proportion of images with artifacts differed significantly between groups. 931
subjects were included in the final analysis. Mean age, race distribution, and sex distribution
across diagnostic groups are presented in table 2.
MRI-structural imaging
Subjects were scanned in 6 sites: Boston (3.0 T, GE Signa); Detroit (3.0 T, Siemens
Allegra); Baltimore (3.0 T, Siemens Trio tim); Hartford (3.0 T, Siemens Allegra); Dallas
(3.0 T, Philips); and Chicago (3.0 T, GE Signa). High-resolution isotropic T1-weighted
MPRAGE scans (TR=6.7 msec, TE=3.1 msec, 8° flip angle, 256×240 matrix size, total scan
duration=10:52.6 minutes, 170 sagittal slices, 1mm slice thickness, 1×1×1.2 mm3 voxel
resolution) were obtained following the Alzheimer's Disease Neuroimaging Initiative
(ADNI) protocol (http://www.loni.ucla.edu/ADNI).
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All images underwent rigorous data quality control. First, images were converted to NIFTI
format and checked for scanner artifacts by trained raters. When images passed this pre-
check, they were run through a first-level auto-reconstruction (auto-recon1) in FreeSurfer
(68). After auto-recon 1, the skull stripped brains were checked for remaining dura or sinus
that could interfere with accurate segmentation. When non-brain tissue was found, images
were edited manually by trained raters. All raters had inter-rater reliabilities (intra-class r)
above 95%. When deemed sufficiently clean for segmentation by an independent rater,
images were run through auto-recon 2 & 3 , i n which gray matter surface area, thickness,
and volume measures were extracted.
Average LGI values were calculated in32 anatomically defined cortical parcellations in each
hemisphere (69); combined they cover the entire cortex. As described and validated by
Schaer et al. (70), LGI was measured by iteratively quantifying GI in spherical 3D regions
of interest. Multiple overlapping spherical regions of interest (~65 cc each) were defined on
the convex hull of the brain and paired with the corresponding cortical surface defined
during FreeSurfer's normal processing. The LGI measure is the ratio of convex hull surface
area to buried cortex surface area.
Statistical analyses
To identify regions showing differences in LGI between groups, we used a hierarchical
approach which minimized risk ofType I error using a process with two steps: 1) a selection
step and 2) a selective analysis. In the selection step, contrasts were run bilaterally on the six
large functionally distinct regions of the brain (frontal, temporal, parietal, occipital,
sensorimotor, and cingulate cortex). The mean LGI value of each of these large regions
(“supra-regions”) was calculated by taking the average LGI value across the given region's
component sub-regions, weighting by the sub-regions' surface areas. When a large region
exhibited a trending difference (p<0.1), it was retained for selective analysis. In this
selective analysis, for each large region passing the selection step, the initial contrast was
run on its component sub-regions, Benjamini-Hochberg adjusting for the number of
subregions. To avoid the problem of “double-dipping” into multiple comparison corrections,
a selection step were first performed on a randomly chosen XA of the sample whereas the
sub-region analysis was performed on the remaining ¾ of the sample. The two steps were
thereby run on independent samples to ensure noncircular analysis (71). Outliers were
handled by winsorising all values greater than three standard deviations from group means.
The effect of lithium was evaluated by employing this hierarwnjafanalysis to compare LGI
values of probands currently using as well as not using lithium. Antipsychotic effect was
evaluated by correlating chlorpromazine (CPZ) equivalent dosage and regional LGI values,
Benjamini-Hochberg adjusting for the number of regions. Because significantil thium effects
were found, lithium usage was included as a categorical covariate in all analyses. No
significant correlations were found between current CPZ equivalent dosage and LGI values,
and so CPZ equivalent dosage was not included as a covariate.
All probands, all non-psychotic relatives, and all relatives with axis II cluster A disorders
were compared to controls using this hierarchical analysis. SZ, SZA, and BP were then also
separately compared to controls and SZ was compared to BP.
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A post-hoc analysis was conducted in which a composite LGI score was calculated by
taking LGI value over brain regions where all probands showed significant differences
compared to controls. The composite scores of all no-psychotic relatives and all relatives
with axis II cluster A disorders were then compared both to controls and probands using
pairwise contrasts.
In regions where all probands differed from controls, probands’ LGI values were correlated
with the riscores on clinical scales, Hochberg adjusting for the total number of correlations.
Familiality was quantified using a maximum likelihood method in Sequential Oligogenic
Linkage Analysis Routines (SOLAR) version 6.2 (72). Significance of heritability was
determined using a maximum likelihood ratio test comparing a model explaining phenotypic
variation by family membership to a model assuming no variation is explained by family
membership.
Sex, race, scanner site, handedness, duration of illness, current lithium usagei current
chloropromazine equivalent usage, age, intracranial volume (ICV), current cognitive ability
(measured by Wide Range Achievement Test IV (WRAT4), a measure of premorbid
intelligence (73)), and socioeconomic status (measured by Hollingshead index (74)) were
tested as potential covariates for analyses. Measures were in cluded as covariates when they
both were significantly associated with regional LGI values (by ANOVAs for categorical
variables and Pearson's correlations for continuous variables, Benjamini-Hochberg adjusting
for the total number of cortical regions) and also differed significantly between controls,
probands, and relatives (by chi-squared tests for categorical variables and ANOVAs for
continuous variables). According to this process, sex, race, scannerisite, lithiumiusage, age,
andi ICV qualified as covariates.
Results
Significant associations with LGI values were observed with sex in 35 regions (p<0.05),
with race in 44 regions (p<0.05), with scanner site in 64 regiofc(p<0.01), with lithium usage
in the right caudal anterior cingulate and right posterior cingulate (p<0.01), with age in 64
regions (p<0.001), and with ICV in 23 regions (p<0.05). No regions showed interactions
between these variables and diagnosis on the LGI imeasures. No significant associations
were found for handedness, chloropromazine equivalent usage, cognitiveiability, and
socioeconomicistatus. For all of theimeasures significantly associated with regional LGI
values, significant differences were found between controls, SZ, SZA, BP, and relatives
(p<0.001), and soisex, race, scanner site, lithium usage, age, and ICV were used as covar
atesiiniall statistical analyses. Mean LGI values varied significantly between probands and
controls in the right poster or cingulate, right caudalianter or cingulate, and left caudal
anterior cingulate brain regions (p<0.05; d=0.17-0.19; Figure 1, Table 3). In these three
regions of observed significant difference, probands exhibited hypogyria i.e., smaller LGI
values. Probands also showed trending hypogyr a comparedito controls in the leftposterior
cingulate (p<0.06; d=0.15; Figure 1; Table 3).
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No significant correlations were found in probands between any clinical measure (PANSS
positive, PANSS negative, MADRS, or YMRS) and LGI values in the four regions of
significant or trending observed probandihypogyria.
Noisignificant differences with controls were found in LGI values of all relatives or relatives
with axis II cluster A disorders. However, in all four regions of significant or trending
observed proband hypogyria, mean LGI values were non-significantly smaller in axis II
cluster A relatives compared with controls (p>0.12, d=0.07-0.22; Table 3). Over these three
regions of observed proband hypogyria, relatives with axis II cluster A disorders exhibited
nearly significant reductions in composite LGI score compared with controls (p<0.051;
d=0.25; Table 3).
Familiality estimates for LGI were modest but significant in 43 of 68 brain regions.
Familiality estimates were significant in all four regions of observed significant or trending
proband hypogyria (p<0.05), with h 2R values ranging from 0.26 in the right posterior
cingulate to 0.45 in the left posterior cingulate (Table 4).
Compared to controls, significant hypogyria was found in the left rostral anterior cingulate
for SZ (p<0.01, d=0.26; Figure 2a, Table 5), left parsopercularis, right inferior parietal, right
banks of the superior temporal sulcus, and right superior temporal for SZA (p<0.05,
d=0.19-0.27; Figure 2b, Table 5), and no regions for BP (Figure 2c). No significant results
were found in the direct SZ-BP comparisons.
Discussion
In this study, we found that patients with DSM-IV psychotic disorders exhibited significant
hypogyria compared with controls in the right pars opercularis, right transverse temporal
gyrus, bilateral posterior cingulate, and bilateral caudal anterior cingulate. Statistically
trending hypogyria compared with controls was also found in patients' right superior frontal
gyrus, right inferior parietal lobe, and left rostral anterior cingulate. The observed patient-
control differences were all in the direction of lower patient gyrification. The consistency of
this finding of hypogyria is particularly notable amid the mixed findings of hypogyria and
hypergyria in previous literature in schizophrenia (Table 1) and in high risk populations
(29-31; 75-77). However, this study's findings appear especially robust given its large
sample size, which was more than three times the size of the next largest comparable study
of which we are aware. These findings are further bolstered by the rigorous use of multiple
comparison corrections and the exclusion of potentially confounded data points, such as
patients using lithium.
The regions of observed patient hypogyria are among the most recently evolved cortical
regions in heteromodal association cortex, which have previously been reported to exhibit
developmental abnormalities in schizophrenia (78-80). Patient hypogyria was particularly
localized bilaterally in the cingulate, suggesting that psychotic disorders may be
characterized by abnormal cingulate connectivity. This observation is consistentwith in vivo
imaging (81) and post-mortem data (82) showing reduced gyral complexity in this brain
region. They are also corroborated by a broader body ofliterature implicating structural,
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function, and neurochemical evidence of cingulate alterations in psychotic disorders (83-95).
This cingulate dysfunction has been postulated to disrupt the modulation of prefronto-
temporal integration in schizophrenia (84). The observed temporal regions ofhypogyria also
are consistent with prior observations of similarly localized surface area, symmetry, and
folding abnormalities in schizophrenia (96-99).
We investigated patient hypogyria as a candidate endophenotype for psychotic disorder
considering the criteria suggested by Gottesman and Gould (5). Our observations lend some
support to this possibility. First, abnormal gyrification was observed to be associated with
psychotic disorder as patients exhibited significant reductions of gyrification compared to
controls in several cortical regions. Second, gyrification was found to be heritable as
familiality estimates were significant, albeit modest, for all six regions of patient hypogyria.
These findings match prior demonstration of gyrification heritability using the two-
dimensional GI measure (17). Third, the lack of significant correlations between patients'
gyrification in regions of abnormality and both their positive and their negative symptoms
points to gyrification being primarily state-independent. Fourth, unaffected family members
with axis II cluster A disorders exhibited a significant reduction in gyrification compared to
controls in composite LGI over regions of patient hypogyria. Non-psychotic relatives with
axis II clusterAdisorders, are characterized by traits such as schizotypy that may reflect the
genetic liability to schizophrenia (50; 51). The small sample size of the axis II cluster A
subset may explain the lack of significance in individual regions since the effect sizes of
were comparable to those in the patient-control comparisons (Table 3). In the right pars
opercularis, the axis II cluster A relatives exhibited markedly reduced gyrification even
compared with patients. The similarity in patients' and this relative subset's patterns
ofhypogyria suggests possible continuity between axis I and axis II disorders (100-104).
Future studies better powered to investigate the gyrification of individuals with axis II
cluster A disorders may help inform this line of research.
The second goal of our study was to evaluate how gyrification abnormalities differ across
psychotic diagnoses. We found that each psychotic diagnosis exhibited a somewhat non-
overlapping profile of gyrification. Schizoaffective disorder patients were observed to have
the most widespread deficits compared to controls. Schizophrenia patients demonstrated
significant hypogyria compared to controls bilaterally in the cingulate. Psychotic bipolar
disorder patients had only one region of significant difference compared to controls.
Although the direct BP-SZ comparison yielded no significant results, these findings of
disparate gyrification profiles relative to controls may lend some support for the divides
between psychotic diagnoses such as schizophrenia, schizoaffective disorder, and psychotic
bipolar disorder. Particularly, the more widespread hypogyria in schizoaffective disorder
and schizophrenia than in bipolar disorder suggests that hypogyria may accompany non-
affective psychosis more than primary affective psychosis. Our results call into question the
construct of the schizoaffective disorder diagnosis. Surprisingly, rather than appearing as a
disorder intermediate to schizophrenia and bipolar disorder, schizoaffective disorder
appeared to exhibit a pronounced profile of hypogyria. It may be that schizophrenia and
affective disorder related genetic factors that may be enriched in this population could
interact to increase the likelihood of altered gyrification.
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Elucidation of brain structural measures such as LGI may also help further understand the
etiopathology of psychotic disorders. Schizophrenia and related psychotic disorders are now
widely held to have neurodevelopmental origins, and genes involved in neurodevelopmental
processes that could impact on gyrification are being increasingly implicated. For example,
genes involved in neuronal adhesion and axonal elongation, such as cadherins and
neuregulin have been implicated in schizophrenia and bipolar disorders. Interestingly, a
recent candidate gene study showed an association in schizophrenia between polymorphisms
of protocadherin 12 (PCDH12), a cell adhesion molecule involved in axonal guidance and
synaptic specificity, and cortical folding (105). These leads need confirmation in larger
genome-wide association studies.
Despite this study's strengths in its novelty, size, using of a whole brain-based three
dimensional approach, and methodological rigor, certain limitations may constrain the
generalizability of these findings. The inclusion criteria for probands, including the need for
the presence of a family member willing and able to participate and cooperation with the
demands of participating in a rigorous research study, may limit the sample
representativeness. The somewhat higher number of exclusions of proband scans with
artifacts may also limit sample representativeness. Although current lithium usage was
included as a covariate and there were no effects of current antipsychotics on LGI, the
possible effect of medication confounds cannot be entirely ruled out, as cumulative usage of
lithium and antipsychotics was not recorded in this study. Also, the cross-sectional nature of
this study precludes the possibility of investigating disease trajectories, which may be
studied by instead employing longitudinal data.
Overall, our findings notably indicate that psychotic disorders are characterized by
hypogyria, particularly localized in the cingulate. They also suggest that hypogyria may be a
structural endophenotype marking clinical and familial risk for psychotic illness across
schizophrenia, schizoaffective, and bipolar diagnostic categories. Hypogyria may thus
provide an intermediate link in the pathway between psychotic disorders' genetic
underpinnings and their clinical syndromes. Given this etiological foothold, next steps
should include determining the genes associated with patient hypogyria. Hypogyria and its
underlying genes may serve as potential means towards drawing more biologically rooted
diagnostic boundaries between psychotic disorders, producing more accurate diagnoses, and
identifying possible targets for treatment and intervention.
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Figure 1.
Effect sizes for regional contrasts demonstrating patient hypogyria
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Figure 2.
Effect sizes for regional contrasts demonstrating hypogyria by diagnosis
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Table 1
Review of gyrification research in schizophrenia after studies reviewed by White and Hilgetag (16)
Authors (Year) Patients (n) Controls (n) Patient population Mean Age (SD) Method for gyrification Significant results
(Patients compared
to controls)
Janssen et al.
(2009) (37)
49 34 First episode, early
onset
15.8 (1.5) LGI N.S.
Schultz et al.
(2010) (19)
54 54 First episode 29.1 (9.4) GI ↑ right
parahippocampal-
lingual cortex
Palaniyappan et
al. (2011) (20)
57 42 Adults 26.1 (7.5) LGI ↓ left middle frontal,
inferior frontal;
bilateral superior
frontal, frontopolar
↑ bilateral
frontomarginal
Haukvik et al.
(2012) (38)
54 54 Adults 41.9 (8.0) LGI N.S.
Palaniyappan &
Liddle (2012)
(22; 23; 39)
57 41 Adults 26.1 (7.5) LGI ↓ left insula, caudal
superior/middle
frontal, parieto-
occipital sulcus,
temporal, precuneus;
bilateral superior
temporal/inferior
parietal junction,
supramarginal
Ronan et al.
(2012) (40)
17 15 Adolescents 16.1 (1.1)
LGI
N.S.
46 44 Adults 33.2 (9.0) ↓ bilateral hemispheres
13 13 Adults 24.8 (4.7) N.S.
Bartholomeusz
et al. (2013)
(26)
96 73 First episode 21.3 (3.3) LGI N.S.
Palaniyappan &
Liddle (2013)
(24)
39 34 Adults 34.0 (2.9) LGI ↓ right caudal middle
frontal, inferior
parietal/superior
temporal, lingual.
↓ left insula,
precuneus/posterior
cingulate,superior and
middle frontal,
supramarginal.
Palaniyappan et
al. (2013) (25)
18 19 Adolescents 16.1 (1.2) LGI ↓ left insula/inferior
frontal, right superior
temporal at 2 years
follow up
↑ Broca's area,
adjacent left insula at 2
years follow up.
Schultz et al.
(2013) (27)
72 72 Adults 28.6 (8.9) Mean Curvature ↑ bilaterally V1, V2,
V5/MT+
Tepest et al.
(2013) (28)
21 21 First episode 27.1 (5.0) GI ↑ frontal and parietal
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Table 3
Descriptive and comparative statistics for Local Gyrification Index (LGI) in regions of significant and
trending proband hypogyria
Large Region Region
Mean LGI (SE)a Effect sizes for contrasts to
controls Cohen's d
Controls (HC) n=243
All
Relatives
(Rel)
n=300
Axis IIA
Relatives
(AxIIA)
n=33
Probands (Prob) n=388
HC-Rel HC-AxIIA HC-Prob
Cingulate
Left Caudal Anterior
Cingulate
1.73 (0.01) 1.72 (0.01) 1.70 (0.02) 1.71 (0.01) 0.087 0.221 0.175**
Left Posterior Cingulate 1.77 (0.01) 1.76 (0.01) 1.76 (0.02) 1.74 (0.01) 0.017 0.074 0.146$
Right Caudal Anterior
Cingulate
1.78 (0.01) 1.78 (0.01) 1.77 (0.02) 1.76 (0.01) 0.022 0.155 0.187**
Right Posterior Cingulate 1.81 (0.01) 1.82 (0.01) 1.80 (0.02) 1.79 (0.01) −0.010 0.146 0.179*
Composite 1.78 (0.01) 1.78 (0.01) 1.76 (0.02) 1.76 (0.01) 0.020 0.247$ 0.130*
*** p<0.001 (All p-values reflect Benjamini-Hochberg adjustment)
aValues adjusted for age, sex, site, race, lithium usage, and intracranial volume
$p < 0.06
*p<0.05
**p<0.01
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Table 4
Heritability values (h2R) for regions of observed significant or trending proband hypogyria
Region h2R (SE)a p
Left Caudal Anterior Cingulate 0.33 (0.13) 0.006**
Left Posterior Cingulate 0.45 (0.13) 0.0004***
Right Caudal Anterior Cingulate 0.31 (0.14) 0.02*
Right Posterior Cingulate 0.26 (0.15) 0.04*
a
Heritability values calculated with a maximum likelihood method in Sequential Oligogenic Linkage Analysis Routines (SOLAR) version 6.2 (68).
*p<0.05
**p<0.01
***p<0.001 (All p-values reflect Benjamini-Hochberg adjustment)
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Table 5
Descriptive and comparative statistics for LGI in all regions where diagnosis groups exhibited significant
hypogyria
Large Region Region
Mean LGI (SE)a Effect sizes for contrasts tocontrols Cohen's d
Controls Schizophrenia (SZ) Schizo-affective (SZA) Psychotic Bipolar (BP) HC-SZ HC-SZA HC-BP
Frontal Left Pars Opercularis 3.38 (0.02) 3.33 (0.02) 3.27 (0.02) 3.40 (0.02) N.S.b 0.269* N.S.b
Parietal Right Inferior Parietal 2.67 (0.01) 2.64 (0.02) 2.62 (0.02) 2.68 (0.02) N.S.b 0.195* N.S.b
Temporal
Right Banks STS 3.23 (0.01) 3.20 (0.02) 3.16 (0.02) 3.24 (0.02) N.S.b 0.226* N.S.b
Right Superior Temporal 2.31 (0.01) 2.30 (0.02) 2.25 (0.02) 2.34 (0.02) N.S.b 0.262* N.S.b
Cingulate Left Rostral Anterior
Cingulate
1.83 (0.01) 1.79 (0.01) 1.82 (0.01) 1.83 (0.01) 0.265** N.S.b N.S.b
N.S. – Not Significant
aValues adjusted for sex, age, site, and race
b
Large region contrast did not justify regional contrast
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